Literature DB >> 6410739

Randomized double-blind cross-over study of iohexol and Amipaque in cerebral angiography.

P Amundsen, G Dugstad, J Presthus, K Sveen.   

Abstract

Iohexol was compared with Amipaque (metrizamide) in a double-blind study in one pair of injections in each of 20 patients referred for routine cerebral angiography. Catheter position, patient position, injection pressure, contrast medium volume, and concentration (300 mg l/ml) were the same in the two injections, with iohexol and Amipaque being used alternately. Except for these two injections iohexol was used throughout. The parameters studied included diagnostic information obtained (quality of the examination), circulation time, and comparison of patient reactions to the pair of injections (e.g., electrocardiogram, heart rate, and subjective reactions). The patients' reactions to the noncomparative part of the examination were evaluated also, and the patients were observed for possible adverse reactions after the examination. No difference could be detected between the two contrast media in this series. No serious adverse reactions occurred.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6410739      PMCID: PMC8335021     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  3 in total

1.  In re: Amundsen P. Cerebral angiography via the femoral artery with particular reference to cerebrovascular disease. Acta Neurol Scand 1967; Suppl. 31:115.

Authors:  A E Rosenbaum; O P Eldevik; J R Mani; A J Pollock; R L Mani; T O Gabrielsen
Journal:  AJNR Am J Neuroradiol       Date:  2001-03       Impact factor: 3.825

2.  Comparison of iohexol 300 mg I/ml and Hexabrix 320 mg I/ml in central angiography. A double-blind trial.

Authors:  J Valk; F Crezée; R G Olislagers-de Slegte
Journal:  Neuroradiology       Date:  1984       Impact factor: 2.804

3.  Complications in cerebral angiography. A comparison between the non-ionic contrast medium iohexol and meglumine metrizoate (Isopaque Cerebral).

Authors:  I O Skalpe; I M Anke
Journal:  Neuroradiology       Date:  1983       Impact factor: 2.804

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.